Next in Terlings Park's pipeline is an antianxiety drug that may have the benefits of Valium without the accompanying drowsiness, temporary memory loss and habit-forming effects.
FORBES: Betting on the brain
Since antianxiety medicine BuSpar went off-patent in April, for instance, sales of the drug have dropped 54%.
FORBES: Drugs of Choice
应用推荐
模块上移
模块下移
不移动